Article
Structure of a protective epitope of group B Streptococcus type III capsular polysaccharide
24 Apr 2017
Abstract excerpt
(GBS) disease with the introduction of intrapartum antibiotic prophylaxis, this pathogen remains a leading cause of neonatal infection. Capsular polysaccharide conjugate vaccines have been tested in phase I/II clinical studies, showing promise for further development. Mapping of epitopes recognized by protective antibodies is crucial for understanding the mechanism of action of vaccines and for enabling antigen...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
